Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.

Formulators of parenteral drugs must be cautious of specific considerations and challenges that arise during development and manufacture. As the numbers of poorly soluble and complex molecules, such ...

For the pharmaceutical industry, drug formulation is a cornerstone, crucial for converting bioactive molecules into effective, stable, and patient-friendly medications. For the pharmaceutical industry ...

According to Theratechnologies, Egrifta WR is set to replace Egrifta SV. The Food and Drug Administration (FDA) has approved Egrifta WR ™, a new concentrated formulation (F8) of tesamorelin, for the ...

In this GEN webinar, our expert speakers will show how Nanoworx combines technical expertise with scalable workflows to support the seamless development of nanomedicines from early discovery and ...

Intrepid Labs’ Valiant platform uses AI and robotics to cut drug formulation timelines from months to days Over $11M USD total raised to-date; latest round led by AVANT BIO TORONTO--(BUSINESS ...

The new formulation significantly reduced injection site pain compared with the original. A new citrate-free formulation of Taltz ® (ixekizumab) has been made available by Eli Lilly. Taltz, an ...

The UK has in recent years recognised the massive contribution which formulation makes to its economic activity. Resources have been made available both through the setting up of CPI’s (Centre for ...